OnabotulinumtoxinA for the treatment of neurogenic detrusor overactivity in children.

Neurourol Urodyn · 2021 · PMC7839517 · PMID 33305474

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

There was a reduction in all dose groups from baseline to Week 6 in the percentage of patients experiencing IDC, with a numerical trend favoring the 100 and 200 U groups (Figure 3C ).

also in 1,012 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.